Kanada - inglise - Health Canada

glaxosmithkline inc - amprenavir - capsule - 150mg - amprenavir 150mg - hiv protease inhibitors

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

avera mckennan hospital - fosamprenavir calcium (unii: id1gu2627n) (amprenavir - unii:5s0w860xnr) - fosamprenavir 700 mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

remedyrepack inc. - fosamprenavir calcium (unii: id1gu2627n) (amprenavir - unii:5s0w860xnr) - fosamprenavir 700 mg

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

a menarini australia pty ltd - avanafil, quantity: 50 mg - tablet, uncoated - excipient ingredients: magnesium stearate; mannitol; fumaric acid; calcium carbonate; hyprolose; iron oxide yellow - treatment of erectile dysfunction in adult males.

Kanada - inglise - Health Canada

viiv healthcare ulc - fosamprenavir (fosamprenavir calcium) - tablet - 700mg - fosamprenavir (fosamprenavir calcium) 700mg - hiv protease inhibitors

Euroopa Liit - inglise - EMA (European Medicines Agency)

glaxo group ltd. - amprenavir - hiv infections - antivirals for systemic use - agenerase, in combination with other antiretroviral agents, is indicated for the treatment of protease inhibitor (pi) experienced hiv-1 infected adults and children above the age of 4 years. agenerase capsules should normally be administered with low dose ritonavir as a pharmacokinetic enhancer of amprenavir (see sections 4.2 and 4.5). the choice of amprenavir should be based on individual viral resistance testing and treatment history of patients (see section 5.1).the benefit of agenerase boosted with ritonavir has not been demonstrated in pi nave patients (see section 5.1)

Euroopa Liit - inglise - EMA (European Medicines Agency)

viiv healthcare bv - fosamprenavir calcium - hiv infections - antivirals for systemic use - telzir in combination with low-dose ritonavir is indicated for the treatment of human-immunodeficiency-virus-type-1-infected adults, adolescents and children of six years and above in combination with other antiretroviral medicinal products. in moderately antiretroviral-experienced adults, telzir in combination with low-dose ritonavir has not been shown to be as effective as lopinavir / ritonavir. no comparative studies have been undertaken in children or adolescents. in heavily pretreated patients, the use of telzir in combination with low-dose ritonavir has not been sufficiently studied. in protease-inhibitor-experienced patients, the choice of telzir should be based on individual viral resistance testing and treatment history.,

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - amprenavir - capsule - 150mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - amprenavir - capsule - 50mg

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - maraviroc 150mg;   - film coated tablet - 150 mg - active: maraviroc 150mg   excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose opadry blue 85g20583 sodium starch glycolate - celsentri, in combination with other antiretroviral medicinal products, is indicated for adult patients infected with only ccr5-tropic hiv-1. the use of other active agents with celsentri is associated with a greater likelihood of treatment response.